Differential loss of heterozygosity profile on chromosome 3p in ductal and lobular breast carcinomas. 2012

Márcia Maria Costa de Oliveira, and Sarah Franco Vieira de Oliveira, and Rubens Silveira Lima, and Cícero de Andrade Urban, and Luciane Regina Cavalli, and Enilze Maria de Souza Fonseca Ribeiro, and Iglenir João Cavalli
Genetics Department, Federal University of Parana, 81531-970 Curitiba, PR, Brazil.

The 2 main histologic types of infiltrating breast cancer, invasive lobular and invasive ductal carcinoma, are morphologically and clinically distinct. Studies revealed that different patterns of gene expression and loss of heterozygosity can also distinguish these 2 subtypes. A whole-genome study using single nucleotide polymorphism array found a significantly higher frequency of loss of heterozygosity on 3p in invasive ductal carcinoma when compared with invasive lobular carcinoma. In this study, we performed a loss of heterozygosity analysis of the 3p chromosome region in ductal and lobular breast tumors. Seven microsatellite markers were evaluated in a series of 136 sporadic breast cancer cases (118 invasive ductal carcinoma and 18 invasive lobular carcinoma) and correlated with clinical-histopathologic parameters from the patients. A significantly higher frequency of loss of heterozygosity was observed in invasive ductal carcinoma (65.3%) when compared with invasive lobular carcinoma (38.9%). When the markers were analyzed separately, loss of heterozygosity at 3 of them, D3S1307 in 3p26.3, D3S1286 in 3p24.3, and D3S1300 in 3p14.2, were significantly more frequent in ductal than in lobular tumors. D3S1307 marker showed the highest frequency of loss of heterozygosity in invasive ductal carcinoma (46.2%), and associations between loss of this marker and loss of estrogen and progesterone receptors were found in these samples. Our results confirm the observations that invasive ductal carcinoma has a higher frequency of loss of heterozygosity events across the 3p region than invasive lobular carcinoma and show that specific losses on 3p26.3, 3p24.3, and 3p14.2 regions are more frequent in ductal than in lobular tumors. We discuss our data in relation to the known tumor suppressor genes that are mapped at the 3p loci investigated and their present relevant roles in breast cancer.

UI MeSH Term Description Entries
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D002893 Chromosomes, Human, Pair 3 A specific pair of human chromosomes in group A (CHROMOSOMES, HUMAN, 1-3) of the human chromosome classification. Chromosome 3
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D016133 Polymerase Chain Reaction In vitro method for producing large amounts of specific DNA or RNA fragments of defined length and sequence from small amounts of short oligonucleotide flanking sequences (primers). The essential steps include thermal denaturation of the double-stranded target molecules, annealing of the primers to their complementary sequences, and extension of the annealed primers by enzymatic synthesis with DNA polymerase. The reaction is efficient, specific, and extremely sensitive. Uses for the reaction include disease diagnosis, detection of difficult-to-isolate pathogens, mutation analysis, genetic testing, DNA sequencing, and analyzing evolutionary relationships. Anchored PCR,Inverse PCR,Nested PCR,PCR,Anchored Polymerase Chain Reaction,Inverse Polymerase Chain Reaction,Nested Polymerase Chain Reaction,PCR, Anchored,PCR, Inverse,PCR, Nested,Polymerase Chain Reactions,Reaction, Polymerase Chain,Reactions, Polymerase Chain
D018270 Carcinoma, Ductal, Breast An invasive (infiltrating) CARCINOMA of the mammary ductal system (MAMMARY GLANDS) in the human BREAST. Carcinoma, Infiltrating Duct,Carcinoma, Invasive Ductal, Breast,Carcinoma, Mammary Ductal,Invasive Ductal Carcinoma, Breast,Mammary Ductal Carcinoma,Carcinomas, Infiltrating Duct,Carcinomas, Mammary Ductal,Mammary Ductal Carcinomas
D018275 Carcinoma, Lobular A type of BREAST CANCER where the abnormal malignant cells form in the lobules, or milk-producing glands, of the breast. Carcinomas, Lobular,Lobular Carcinoma,Lobular Carcinomas
D019656 Loss of Heterozygosity The loss of one allele at a specific locus, caused by a deletion mutation; or loss of a chromosome from a chromosome pair, resulting in abnormal HEMIZYGOSITY. It is detected when heterozygous markers for a locus appear monomorphic because one of the ALLELES was deleted. Allelic Loss,Heterozygosity, Loss of,Allelic Losses,Heterozygosity Loss

Related Publications

Márcia Maria Costa de Oliveira, and Sarah Franco Vieira de Oliveira, and Rubens Silveira Lima, and Cícero de Andrade Urban, and Luciane Regina Cavalli, and Enilze Maria de Souza Fonseca Ribeiro, and Iglenir João Cavalli
December 1993, The American journal of pathology,
Márcia Maria Costa de Oliveira, and Sarah Franco Vieira de Oliveira, and Rubens Silveira Lima, and Cícero de Andrade Urban, and Luciane Regina Cavalli, and Enilze Maria de Souza Fonseca Ribeiro, and Iglenir João Cavalli
March 1996, Oncology reports,
Márcia Maria Costa de Oliveira, and Sarah Franco Vieira de Oliveira, and Rubens Silveira Lima, and Cícero de Andrade Urban, and Luciane Regina Cavalli, and Enilze Maria de Souza Fonseca Ribeiro, and Iglenir João Cavalli
October 2006, Zhonghua wai ke za zhi [Chinese journal of surgery],
Márcia Maria Costa de Oliveira, and Sarah Franco Vieira de Oliveira, and Rubens Silveira Lima, and Cícero de Andrade Urban, and Luciane Regina Cavalli, and Enilze Maria de Souza Fonseca Ribeiro, and Iglenir João Cavalli
January 2002, Breast cancer research : BCR,
Márcia Maria Costa de Oliveira, and Sarah Franco Vieira de Oliveira, and Rubens Silveira Lima, and Cícero de Andrade Urban, and Luciane Regina Cavalli, and Enilze Maria de Souza Fonseca Ribeiro, and Iglenir João Cavalli
September 1995, Journal of the National Cancer Institute,
Márcia Maria Costa de Oliveira, and Sarah Franco Vieira de Oliveira, and Rubens Silveira Lima, and Cícero de Andrade Urban, and Luciane Regina Cavalli, and Enilze Maria de Souza Fonseca Ribeiro, and Iglenir João Cavalli
May 2008, Zhonghua bing li xue za zhi = Chinese journal of pathology,
Márcia Maria Costa de Oliveira, and Sarah Franco Vieira de Oliveira, and Rubens Silveira Lima, and Cícero de Andrade Urban, and Luciane Regina Cavalli, and Enilze Maria de Souza Fonseca Ribeiro, and Iglenir João Cavalli
June 1998, Journal of Korean medical science,
Márcia Maria Costa de Oliveira, and Sarah Franco Vieira de Oliveira, and Rubens Silveira Lima, and Cícero de Andrade Urban, and Luciane Regina Cavalli, and Enilze Maria de Souza Fonseca Ribeiro, and Iglenir João Cavalli
October 1996, Genes, chromosomes & cancer,
Márcia Maria Costa de Oliveira, and Sarah Franco Vieira de Oliveira, and Rubens Silveira Lima, and Cícero de Andrade Urban, and Luciane Regina Cavalli, and Enilze Maria de Souza Fonseca Ribeiro, and Iglenir João Cavalli
January 2008, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology,
Márcia Maria Costa de Oliveira, and Sarah Franco Vieira de Oliveira, and Rubens Silveira Lima, and Cícero de Andrade Urban, and Luciane Regina Cavalli, and Enilze Maria de Souza Fonseca Ribeiro, and Iglenir João Cavalli
November 1995, Cancer research,
Copied contents to your clipboard!